Published in Gene Therapy Weekly, May 13th, 1996
Having utilized a murine model for in vivo studies, Sunil K. Chatterjee presented data at the 87th Annual Meeting of the American Association for Cancer Research, held April 20-24, 1996, in Washington, D.C., which suggested that the use of recombinant vaccinia viruses to transfect cancer cells with GM-CSF have a place in cancer gene therapy.
"The advantages of this system include its ability to treat almost any type of cancer," remarked Chatterjee. "It can be used by either...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.